Loomis Sayles & CO L P Bicycle Therapeutics PLC Transaction History

Loomis Sayles & CO L P

  • $76.2 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 05, 2022
SELL
$12.95 - $46.99 $8.34 Million - $30.3 Million
-643,775 Closed
0 $0
Q1 2022

May 13, 2022
BUY
$40.12 - $59.5 $2.96 Million - $4.39 Million
73,728 Added 12.93%
643,775 $28.2 Million
Q4 2021

Feb 14, 2022
BUY
$41.7 - $61.14 $23.8 Million - $34.9 Million
570,047 New
570,047 $34.7 Million

Others Institutions Holding BCYC

# of Institutions
111
Shares Held
40.8M
Call Options Held
39.6K
Put Options Held
24.6K
View Full List

About BICYCLE THERAPEUTICS plc

BCYC Quotes by TradingView
  • Ticker BCYC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 29,676,100
  • Market Cap $436M
  • Description
  • Bicycle Therapeutics plc, a clinical-stage biopharmaceutical company, develops a class of medicines for diseases that are underserved by existing therapeutics. Its lead product candidate is BT1718, a bicycle toxin conjugate (BTC), which is in Phase I/IIa clinical trials targeting tumors that express Membrane Type 1 matrix metalloprotease. The co...
More about BCYC
Track This Portfolio

Track Loomis Sayles & CO L P Portfolio

Follow Loomis Sayles & CO L P and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Loomis Sayles & CO L P, based on Form 13F filings with the SEC.

News

Stay updated on Loomis Sayles & CO L P with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email